1. Home
  2. INDI vs SPRY Comparison

INDI vs SPRY Comparison

Compare INDI & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$5.25

Market Cap

906.0M

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.40

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
SPRY
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.0M
788.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
INDI
SPRY
Price
$5.25
$9.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$6.25
$40.00
AVG Volume (30 Days)
5.7M
1.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
N/A
EPS
N/A
N/A
Revenue
$217,394,000.00
$84,278,000.00
Revenue This Year
$25.54
$87.40
Revenue Next Year
$38.45
$81.64
P/E Ratio
N/A
N/A
Revenue Growth
0.33
N/A
52 Week Low
$2.32
$6.66
52 Week High
$6.05
$18.63

Technical Indicators

Market Signals
Indicator
INDI
SPRY
Relative Strength Index (RSI) 70.74 64.81
Support Level $5.16 $7.82
Resistance Level $6.01 $9.51
Average True Range (ATR) 0.39 0.59
MACD 0.06 0.11
Stochastic Oscillator 86.74 92.22

Price Performance

Historical Comparison
INDI
SPRY

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: